Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.

  title={Diagnostic efficacy of myeloperoxidase for the detection of acute coronary syndromes.},
  author={Marcin Sawicki and Grażyna Sypniewska and Marek Koziński and Marzenna Gruszka and Magdalena Krintus and Karolina Obońska and Marta Pilaczyńska-Cemel and Jacek Kubica},
  journal={European journal of clinical investigation},
  volume={41 6},
BACKGROUND Early diagnosis of acute coronary syndrome (ACS) is frequently a challenging task, while immediate risk stratification remains crucial for the prompt implementation of appropriate therapy in this setting. Employing markers that increase rapidly after the symptom onset may enhance triage and therapeutic decision-making in patients suspected for ACS. Myeloperoxidase (MPO) exerting proinflammatory and pro-oxidative properties is suggested as a reliable early marker for ACS associated… CONTINUE READING


Publications citing this paper.
Showing 1-10 of 10 extracted citations

Role of serum myeloperoxidase, CPK, CK-MB, and cTnI tests in early diagnosis of myocardial ischemia during ERCP.

The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology • 2014
View 3 Excerpts


Publications referenced by this paper.
Showing 1-10 of 14 references

patients with chest pain

SL Hazen
Clin Biochem 2010;43:240–5 • 2010

Plasma level

L Kubala, G Lu, S Baldus, L Berglund, JP. Eiserich
tion. Transpl Immunol 2009;20:121–6 • 2009

The use of biochip cardiac array technology for early diagnosis of acute coronary syndromes

TK Rudolph, M Hillebrandt
J Med Biochem • 2009

Effect of collection tube type and preanalytical handling on myeloperoxidase concentrations

S Schaffellner
Clin Chem • 2008

Myeloperoxidase and plaque vulnerability

A Maseri
Arterioscler Thromb Vasc Biol • 2004

Similar Papers

Loading similar papers…